Trial Profile
A phase II study of CPT-11 [irinotecan] in patients with advanced gallbladder or bile duct tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 15 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 18 Sep 2005 New trial record.